NOTICIAS CIENTÍFICAS…
465
Aradhye, S.; Burtin, P. “Fingolimod (FTY720): discovery and development of an oral drug
to treat multiple sclerosis”
Nat. Rev. Drug Discov
.
2010
,
9
, 883-‐897. b) Vasiliou, S. “Oral
Fingolimod for the treatment of relapsing-‐remitting multiple sclerosis”
Drugs Today
2010
,
46
, 315-‐325.
14.
Compston A, Coles A. Multiple sclerosis.
Lancet.
2002
,
359
,1221-‐1231.
15. a) Putzki, N.; Baranwal, M. K.; Tettenborn, B.; Limmroth, V.; Kreuzfelder, E. “Effects of
natalizumab on circulating B cells: T regulatory cells and natural killer cells”,
Eur. Neurol
.
2010; 63, 311-‐317. b) Buttmann, M. “Treating multiple sclerosis with monoclonal
antibodies: a 2010 update”
Expert Rev. Neurother.
2010, 10, 791-‐809. c) Niino, M.; Sasaki,
H. “Update on the treatment options for multiple sclerosis”
Expert Rev. Clin. Immunol.
2010
,
6
, 77-‐88.
16.
Comi, G.; Jeffery, D.; Kappos, L.; Montalban, X.; Boyko, A.; Rocca, M. A.; Filippi, M.; Allegro
Study, G. "Placebo-‐Controlled Trial of Oral Laquinimod for Multiple Sclerosis"
New Engl, J.
Med
.
2012
,
366
, 1000-‐1009.
17. a) Igarashi, N. et al. Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis.
J.
Biol. Chem
. 2003, 278, 46832-‐46839. b) Hait, N.C. et al. “Regulation of histone acetylation
in the nucleus by sphingosine-‐ 1-‐phosphate”
Science
2009
,
325
, 1254-‐1257.
18. Carey, N.; La Thangue, N. B.
Curr. Opin. Pharmacol.
2006
,
6
, 369.
19. Fischer, A.; Sananbenesi, F.; Mungenast, A.; Tsai, L. H. “Targeting the correct HDAC(s) to
treat cognitive disorders”
Trends Pharmacol. Sci
.
2010
,
31
, 605-‐617.
20. Brynskikh, A.: Warren, T.; Zhu, J.; Kipnis, J. “Adaptive immunity affects learning behavior in
mice”
Brain Behav. Immun
.
2008
,
22
, 861-‐869.
21. Brynskikh, A., Warren, T., Zhu, J., Kipnis, J. “Adaptive immunity affects learning behavior in
mice”
Brain Behav. Immun
.
2008
,
22
, 861-‐869.
22. Matheos, D. P.; Word, M. A. “Unlocking the constraints on memory formation”,
Nature
Neurosc
.
2014
,
17
, 895-‐896.
23. Flores, A.; Valls-‐Comamala, V.; Costa, G.; Saravia, R.; Maldonado, R.; Berrendero, F. “The
Hypocretin/Orexin System Mediates the Extinction of Fear Memories”
Neuropsychopharmacology
2014
doi: 10.1038/npp.2014.146.
